Novartis Hopes Lubris In-Licensing Deal Will Lead To Dry Eye Solution

ON the lookout for potential ophthalmology options despite recent setbacks in the area, Novartis has now spotted ECF843, an investigative recombinant human lubricin – or natural lubricant – for dry eye.

Climate change

More from Business

More from Scrip